Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Dicloxacillin

A beta-lactamase-resistant penicillin of the isoxazolyl penicillin family, patented in 1961 and approved for medical use in 1968: it is used mainly against staphylococcal infections of the skin and bones. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.

Did you know?The prefix 'di-' recalls the two chlorine atoms on the phenyl ring of its side chain; together with the isoxazolyl group, this side chain shields it from the enzymes bacteria use to destroy penicillin.

DicloxacillinGo to the active ingredient →
DicloxacillinActive ingredientDicloxacillinCat. No. P-D096-001CAS 3116-76-5

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.